Your Cart ( 3 Items )

• Biologic Therapy for Psoriasis: An Update on the Tumor Necrosis Factor Inhibitors Infliximab, Etanercept, and Adalimumab, and the T-Cell-Targeted Therapies Efalizumab and Alefacept
  September 2005 | Volume 4 | Issue 5 | Original Article | 544 | Copyright © September 2005
  Jeffrey M. Weinberg MD, Clement J. Bottino BA, James Lindholm BA, Robin Buchholz MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• PIPELINE PREVIEWS
  January 2012 | Volume 11 | Issue 1 | Features | 130 | Copyright © January 2012
  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• New-Onset Vitiligo During Long-Term, Stable Infliximab Treatment of Pityriasis Rubra Pilaris
  February 2013 | Volume 12 | Issue 2 | Case Reports | 217 | Copyright © February 2013
  Adam R. Mattox DO MS, Jeaneen A. Chappell MD, and M. Yadira Hurley MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs